I'm currently delivering data strategy and analytics projects for eight CVRM and R&I brands at Chryselys, with work implemented across four oncology therapy areas.
I build HCP targeting tools and prioritized lists using claims, lab, clinical-trial, publications, guidelines, conference, Open Payments, NPPES, Citeline, and IQVIA APLD data. My work includes a Clinical Trial Investigator tool and prediction-based targeting for prostate cancer products.
Previously at Harman Connected Services and ZS Associates, I analyzed patient-level data, treatment journeys, physician preferences, drug compliance, persistency, and market performance across rare disease, atopic dermatitis, skin cancer, and severe asthma. I identified 15% market penetration within one year for a skin cancer launch and a 20% opportunity to increase market share.
I also lead an RWD analytics client pod of six team members, interview technical candidates, and train freshers in RWD and SQL.
